upgrading the sequential therapy tool kit for b-cell malignancies
Published 2 years ago • 131 plays • Length 1:09:38Download video MP4
Download video MP3
Similar videos
-
1:03:37
interprofessional perspectives on safety management with targeted therapy for b-cell malignancies
-
1:01
comparing btk inhibitors in patients with b-cell malignancies
-
1:12:28
perspectives on innovative treatment for b-cell malignancies
-
1:30
bispecific antibodies for r/r aggressive b-cell lymphomas
-
22:36
progress with btk inhibitors: a journey through the mechanisms of covalent and noncovalent options
-
14:05
was this tool kit worth $59?
-
5:50
what is the most promising novel agent for the treatment of aggressive b-cell lymphoma?
-
3:45
update from soho 2020 on follicular lymphoma
-
1:05:12
update on follicular lymphoma | lrf webinars
-
3:10
clinical trials and research for diffuse large b-cell lymphoma
-
1:32:21
solving the puzzles for b-cell malignancies: navigating the place of btk inhibitors today and tom...
-
1:05
nkx019 in b-cell malignancies
-
43:40
polatuzumab vedotin in previouslyuntreated diffuse large b-cell lymphoma.
-
58:11
crafting the new treatment mix in cll
-
8:24
keytruda for treatment of refractory primary mediastinal large b-cell lymphoma (pmbcl)
-
1:21
the new universal bit kit!
-
58:24
update on diffuse large b-cell lymphoma | lrf webinars
-
1:05
btk degraders for treatment of cll and b-cell lymphoma
-
55:56
new biological insights and novel strategies in aggressive b-cell lymphoma